Company news

Share this article:
MANUFACTURER NEWS
Astellas Pharma Technologies is offering early retirement to 200 workers at its Norman, OK, plant. The cuts anticipate the patent expiration Flomax.
 
Merck KGaA, the German manufacturer of Erbitux cancer treatment, has announced a partnership with Belgian biotech Ablynx NV to develop tumor and immune disorder treatments. 
 
 
AGENCY NEWS
Concentric Pharma Advertising has won an AOR assignment on Surfaxin, an investigational respiratory distress syndrome (RDS) treatment manufactured by Discovery Labs.
Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.